CONy 2023 | Informing iRBD patients about potential PD development

Idiopathic REM sleep behavior disorder (iRBD) is a powerful predictor of neurodegenerative synucleinopathies, including Parkinson’s disease. Michael Ugrumov, MD, PhD, Koltzov Institute of Developmental Biology, Russian Academy of Sciences, Moscow, Russia, debates whether iRBD patients should be informed about the potential development of Parkinson’s disease. This question raises ethical and practical considerations, especially as no disease-modifying treatments are available. This interview took place at the 17th World Congress on Controversies in Neurology (CONy) in Dubrovnik, Croatia.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.